|
24 Mar 2020 |
eTheRNA Launches an International Consortium and Starts Development of Cross-strain Protective CoV-2 mRNA Vaccine for High Risk Populations
|
|
24 Mar 2020 |
Ufovax successfully extended its Nanoparticle vaccine technology to SARS-CoV-2
|
|
24 Mar 2020 |
Triumvira Immunologics and Lonza Announce Collaboration to Develop Innovative Point-of-Care Manufacturing for TAC T-Cell Therapeutic Targeting Solid Tumors
|
|
24 Mar 2020 |
Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant
|
|
24 Mar 2020 |
First-of-its-kind Engineered Macrophage Cell Therapy Platform Shows Ability to Reduce Tumor Burden and Activate Anti-Tumor Immunity, Improving Overall Survival in Pre-Clinical Cancer Models
|
|
24 Mar 2020 |
Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
|
|
24 Mar 2020 |
CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop Probody® T-Cell Engaging Bispecific Therapies for Treatment of Cancer
|
|
24 Mar 2020 |
Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment
|
|
24 Mar 2020 |
AveXis presents AVXS-101 IT data demonstrating remarkable increases in HFMSE scores and a consistent clinically meaningful response in older patients with SMA Type 2
|
|
24 Mar 2020 |
Zolgensma® data shows rapid, significant, clinically meaningful benefit in SMA including prolonged event-free survival, motor milestone achievement and durability now up to 5 years post-dosing
|
|
24 Mar 2020 |
Pieris Pharmaceuticals Provides Update on Servier Collaboration
|
|
24 Mar 2020 |
Secarna Pharmaceuticals announces the acquisition of LNAplus based antisense drug candidates by Lipigon Pharmaceuticals
|
|
23 Mar 2020 |
Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States
|
|
23 Mar 2020 |
Regulatory authorities approve JTA Phase III study in osteoarthritic knee pain and ALLOB Phase IIb study in difficult fractures
|
|
23 Mar 2020 |
Agios Announces FDA Clearance of Investigational New Drug Application for AG-946, a Next-Generation PKR Activator
|
|
23 Mar 2020 |
Codexis Signs Strategic Collaboration and License Agreement with Takeda to Advance Novel Gene Therapies for Rare Genetic Disorders
|
|
23 Mar 2020 |
Sorrento and Smartpharm to collaborate to develop novel gene-encoded antibody vaccine intended to protect against COVID-19
|
|
23 Mar 2020 |
Pliant Therapeutics Initiates First-in-Human Clinical Trial of PLN-1474 for the Potential Treatment of Liver Fibrosis
|
|
23 Mar 2020 |
Hoth Therapeutics Announces Agreement to Joint Development for a Self-Assembling Vaccine (SAV) for the Potential Prevention of the Coronavirus (COVID-19)
|
|
23 Mar 2020 |
NeoImmuneTech Enters into Exclusive License Agreement with Ubix Therapeutics to Develop Drug Candidates Including T Cell Suppressor Blockade
|
